The prognostic value of CINSARC in a randomised trial comparing histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001).

被引:0
|
作者
Pasquali, Sandro
Braglia, Luca
Chibon, Frederic
Coindre, Jean Michel
Italiano, Antoine
Romagosa, Cleofe
Bague, Silvia
Dei Tos, Angelo Paolo
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Beveridge, Robert Diaz
Stacchiotti, Silvia
Merlo, Domenico F.
Casali, Paolo Giovanni
Gronchi, Alessandro
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Milan, Italy
[2] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Sul Canc, Clin Trial Ctr, Genoa, Italy
[3] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Sul Canc, Dept Epidemiol, Genoa, Italy
[4] Inst Bergonie, Bordeaux, France
[5] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[6] H Vall dHebron, Barcelona, Spain
[7] Hosp St Pau & Santa Creu, Pathol Dept, Barcelona, Spain
[8] Padua Univ Hosp, Padua, Italy
[9] IRCCS Ist Ortoped Rizzoli, Bologna, Italy
[10] Ist Clin Humanitas, Milan, Italy
[11] Univ Seville, Inst Biomed Res IBIS, CSIC, Virgen del Rocio Univ Hosp, Seville, Spain
[12] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[13] IRCCS, FPO, Candiolo Canc Inst, Div Med Oncol, Candiolo, TO, Italy
[14] Ist Oncol Veneto IOV IRCCS, Dept Oncol, Med Oncol Unit 1, Padua, Italy
[15] Ctr Leon Berard, Unicanc, Lyon, France
[16] Med Oncol Dept, Valencia, Spain
[17] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[18] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Mesenchymal & Rare Tumor Unit, Milan, Italy
[19] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Sarcoma Serv, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e23531
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
    Stacchiotti, S.
    Verderio, P.
    Messina, A.
    Morosi, C.
    Ferraro, A.
    Quagliuolo, V.
    Martin, J.
    Comandone, A.
    Grignani, G.
    Picci, P.
    Frustaci, S.
    Gronchi, A.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
    Berclaz, Luc M.
    Altendorf-Hofmann, Annelore
    Duerr, Hans Roland
    Klein, Alexander
    Angele, Martin K.
    Albertsmeier, Markus
    Schmidt-Hegemann, Nina-Sophie
    Di Gioia, Dorit
    Knoesel, Thomas
    Lindner, Lars H.
    CANCERS, 2021, 13 (19)
  • [33] Localized, high-risk soft tissue sarcomas (STS) of the extremities and trunk wall in adults: Three versus five cycles of full-dose anthracyclin and ifosfamide adjuvant chemotherapy: A phase III randomized trial from the Italian Sarcoma Group (ISG) and Spanish Sarcoma Group (GEIS)
    Gronchi, A.
    Frustaci, S.
    Mercuri, M.
    Broto, J. Martin
    Lopez-Pousa, A.
    Mariani, L.
    Verderio, P.
    Quagliuolo, V.
    Casali, P. G.
    Picci, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation therapy oncology group trial 9514
    Kraybill, WG
    Harris, J
    Spiro, IJ
    Ettinger, DS
    DeLaney, TF
    Blum, RH
    Lucas, DR
    Harmon, DC
    Letson, GD
    Eiaberg, B
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 619 - 625
  • [35] A PROSPECTIVE RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY WITH BOLUS VERSUS CONTINUOUS INFUSION OF DOXORUBICIN IN PATIENTS WITH HIGH-GRADE EXTREMITY SOFT-TISSUE SARCOMA AND AN ANALYSIS OF PROGNOSTIC FACTORS
    CASPER, ES
    GAYNOR, JJ
    HAJDU, SI
    MAGILL, GB
    TAN, C
    FRIEDRICH, C
    BRENNAN, MF
    CANCER, 1991, 68 (06) : 1221 - 1229
  • [36] Dissecting the role of tumor-infiltrating lymphocytes (TIL) in patients with high-risk soft-tissue sarcoma (STS) receiving neo-adjuvant chemotherapy (NAC) with regional hyperthermia (RHT)
    Issels, R.
    Bueclein, V.
    Kampmann, E.
    Knoesel, T.
    Noessner, E.
    Subklewe, M.
    Lindner, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients:: results of a randomised study comparing high-dose chemotherapy followed by autologous stem cell transplantation with standard-dose chemotherapy
    Kröger, N
    Milde-Langosch, K
    Riethdorf, S
    Schmoor, C
    Zander, A
    Löning, T
    BONE MARROW TRANSPLANTATION, 2005, 35 : S2 - S3
  • [38] Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
    Issels, Rolf D.
    Noessner, Elfriede
    Lindner, Lars H.
    Schmidt, Michael
    Albertsmeier, Markus
    Blay, Jean-Yves
    Stutz, Emanuel
    Xu, Yujun
    Buecklein, Veit
    Altendorf-Hofmann, Annelore
    Abdel-Rahman, Sultan
    Mansmann, Ulrich
    von Bergwelt-Baildon, Michael
    Knoesel, Thomas
    EUROPEAN JOURNAL OF CANCER, 2021, 158 : 123 - 132
  • [39] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
    Gronchi, Alessandro
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Ferraresi, Virginia
    Lugowska, Iwona
    Pizzamiglio, Sara
    Verderio, Paolo
    Fontana, Valeria
    Donati, Davide Maria
    Palassini, Elena
    Stacchiotti, Silvia
    Miceli, Rosalba
    Tos, Angelo Paolo Dei
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Updated analysis of a phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation therapy oncology group trial 9514
    Kraybill, W. G.
    Harris, I. J.
    Spiro, I. J.
    Ettinger, D. S.
    Letson, G. D.
    DeLaney, T. F.
    Blum, R. H.
    Lucas, D. R.
    Harmon, D. C.
    Eisenberg, B.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 17 - 17